Bill Berkrot

LOS ANGELES (Reuters) - Amgen Inc's experimental cholesterol-lowering drug, AMG145, reduced levels of "bad" cholesterol up to 66 percent in patients already taking statin drugs, according to results from a...

LOS ANGELES (Reuters) - An experimental Novartis AG drug to treat hospitalized acute heart failure patients reduced deaths by 37 percent compared with a placebo and appeared to be safe,...

LOS ANGELES (Reuters) - A simple tweak to implanted defibrillators used to detect and correct dangerous heart rhythms not only dramatically reduced unnecessary shocks but cut deaths by 55 percent...

(Reuters) - Stem cells culled from the bone marrow of healthy donors work as well or even better as cells harvested from patients themselves as a treatment for damaged hearts...

LOS ANGELES (Reuters) - Taking a daily multivitamin does not reduce the risk of heart disease for older men, according to data from a large study presented on Monday. About...

LOS ANGELES (Reuters) - Diabetics with more than one diseased artery fared significantly better if they underwent bypass surgery than those who received drug coated stents following artery clearing procedures...

LOS ANGELES (Reuters) - Angioplasty to clear blocked arteries costs more at hospitals not equipped for emergency heart surgery, according to a study presented on Sunday at the American Heart...

LOS ANGELES (Reuters) - Diabetics with more than one diseased artery fared significantly better if they underwent bypass surgery than those who received drug coated stents following artery clearing procedures...

(Reuters) - Vertex Pharmaceuticals Inc reported a net loss for the third quarter on Thursday with results hurt by fast-declining sales of its Incivek hepatitis C drug, as the company...

(Reuters) - Vertex Pharmaceuticals Inc reported a net loss for the third quarter on Thursday with results hurt by fast-declining sales of its Incivek hepatitis C drug, as the company...